Transcript : Exelixis, Inc. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-10-2025 10
Transcript : Exelixis, Inc. Presents at Guggenheim Securities 2nd Annu…
4 months ago
zonebourse.com
Exelixis Near A Buy Point. Relative Strength Rating Climbs.
Exelixis Near A Buy Point. Relative Strength Rating Climbs.
2 months ago
investors.com
Exelixis, Inc. présente les résultats détaillés de l'essai pivot de phase 3 STELLAR-303 sur le zanzalintinib en association avec un inhibiteur de point de contrôle immunitaire dans le cancer colorectal métastatique à l'ESMO 2025
Exelixis, Inc. présente les résultats détaillés de l'essai pivot de phase …
4 months ago
zonebourse.com
Search Careers at Exelixis
Search Careers at Exelixis
Sep 28, 2024
exelixis.com
Why Exelixis, Inc. Continued Its Downfall Today
Why Exelixis, Inc. Continued Its Downfall Today
Oct 4, 2019
nasdaq.com
Exelixis, Inc. Elects Dave Johnson to its Board of Directors
Exelixis, Inc. Elects Dave Johnson to its Board of Directors
May 31, 2023
marketscreener.com
Exelixis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
Exelixis, Inc. Reports Earnings Results for the Full Year Ended De…
Dec 31, 2024
marketscreener.com
Exelixis, Inc.: Exelixis' Partner Ipsen Receives European Commission …
7 months ago
finanznachrichten.de
Exelixis | LinkedIn
Aug 23, 2015
linkedin.com
Gráfico avanzado e interactivo de Exelixis (EXEL) - Investing.com
8 months ago
investing.com
Exelixis Hits 80-Plus Relative Strength Rating Benchmark
3 months ago
investors.com
Biotech Leader Exelixis Eyes Buy Point In Monday's Stock Market R…
11 months ago
investors.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation …
7 months ago
wwlp.com
Here's What Crushed Exelixis' Earnings | The Motley Fool
Jun 6, 2021
fool.com
Exelixis (EXEL) Late-Stage Study in Pancreatic Tumors Positive
Aug 25, 2023
nasdaq.com
Why Exelixis Is Already Up 55% This Year | The Motley Fool
Mar 15, 2017
fool.com
Is Exelixis Stock a Buy After Its Disappointing Liver Cancer Study …
Jul 9, 2021
fool.com
2:00
Exelixis CEO: 30,000 men will die of prostate cancer this year
Jan 14, 2014
CNBC
21:40
For HCPs: CABINET data. Real-world dialogue
14 views1 month ago
YouTubeCABOMETYX® (cabozantinib)
21:33
For HCPs: Post progression. What’s Next?
1 views1 month ago
YouTubeCABOMETYX® (cabozantinib)
21:16
For HCPs: Dr. Alter and Dr. Shameem discuss COSMIC-311
1 month ago
YouTubeCABOMETYX® (cabozantinib)
21:55
For HCPs: Perspectives on key CELESTIAL data
17 views1 month ago
YouTubeCABOMETYX® (cabozantinib)
20:49
For HCPs: Dosing and management with CABOMETYX
1 month ago
YouTubeCABOMETYX® (cabozantinib)
26:11
For HCPs: CheckMate 9ER Treatment Discussion with Dr. Ge…
1 views1 month ago
YouTubeCABOMETYX® (cabozantinib)
7:52
สรุปหุ้น EXEL ใน 8 นาที: ทำธุรกิจอะไร น่าลงทุนไหมในป…
1 month ago
YouTubeAI ให้หุ้น
0:25
Revitalize Your Body with Exilis Treatment
108K viewsMar 6, 2025
TikTokprecision.aestheticsmd
0:34
A big New Year's toast to every volunteer who showed up for Oakl…
179 views2 months ago
FacebookEat Learn Play Foundation
On International Thank You Day, we would like to thank our Corporate …
1 month ago
linkedin.com
Cancion de Boo - Monsters Inc.
70.9M viewsDec 5, 2009
YouTubeluisin1089
A $1,000,000 Stock Analysis Masterclass for FREE | Martin Shk…
24.6K viewsMar 3, 2023
YouTubeThe Shkreli Pill
See more videos
Static thumbnail place holder